BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1388082)

  • 1. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
    Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acral erythema after allogeneic graft of the bone marrow].
    Dechaufour F; Dompmartin A; Troussard X; Galateau F; Pedailles S; Remond B; Leporrier M; Leroy D
    Ann Dermatol Venereol; 1993; 120(3):219-22. PubMed ID: 8239360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation.
    Crider MK; Jansen J; Norins AL; McHale MS
    Arch Dermatol; 1986 Sep; 122(9):1023-7. PubMed ID: 3527075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acral erythemas induced by chemotherapy and graft-versus-host disease in adults with hematogenous malignancies.
    Horwitz LJ; Dreizen S
    Cutis; 1990 Nov; 46(5):397-404. PubMed ID: 2148142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
    Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
    Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ; Strutton GM; Robertson IM; Weedon D
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
    Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Au WY; Chan AC; Lie AK; So JC; Liang R; Kwong YL
    Bone Marrow Transplant; 1998 Jul; 22(1):99-102. PubMed ID: 9678803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
    Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
    Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pustular acral erythema in a patient with acute graft-versus-host disease.
    Ruiz-Genao DP; GF-Villalta MJ; Peñas PF; Fraga J; García-Díez A; Fernández-Herrera J
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):550-3. PubMed ID: 12941091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE; McKee PH; Nghiem P
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
    Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
    Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
    Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.